Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma

Lam, John S., Shvarts, Oleg, Said, Jonathan W., Pantuck, Allan J., Seligson, David B., Aldridge, Michael E., Bui, Matthew H. T., Liu, Xueli, Horvath, Steve, Figlin, Robert A., Belldegrun, Arie S.·2005·Cancer

Abstract

BACKGROUND: The presence of histologic necrosis in the primary tumor of patients with renal cell carcinoma (RCC) has been suggested to be an important predictor of survival. The authors investigated the relation of tumor necrosis to other clinicopathologic factors known to be important prognostic indicators for patients with RCC. METHODS: The records of 311 patients undergoing treatment for RCC were evaluated for basic clinicopathologic information including TNM classification, nuclear grade, Eastern Cooperative Oncology Group (ECOG) performance status (PS), disease recurrence, and survival. The presence and extent of histologic necrosis of the primary tumors was recorded and correlated with clinicopathologic factors, carbonic anhydrase IX and Ki‐67 expression, disease recurrence, and survival. RESULTS: The presence of necrosis in the primary tumor of patients with RCC compared with patients with RCC without necrosis was associated with higher T classification (P < 0.0001), the presence of lymph node disease (P = 0.009), the presence of metastases (P < 0.0001), higher grade (P < 0.0001), greater mean tumor size (P < 0.0001), an ECOG PS score ≥ 1 (P = 0.007), higher University of California‐Los Angeles Integrated Staging System (UISS) category (P < 0.0001), and higher Ki‐67 expression (P < 0.0001). The extent of necrosis in the primary tumor was associated with the presence of lymph node disease (P = 0.009) and the presence of metastases (P < 0.0001), and correlated with higher T classification (σ = 0.31, P < 0.0001), poorer ECOG PS (σ = 0.18, P = 0.002), higher grade (σ = 0.33, P < 0.0001), greater tumor size (σ = 0.40, P < 0.0001), higher UISS category (σ = 0.37, P < 0.0001), and higher Ki‐67 staining (σ = 0.32, P < 0.0001). Patients with the presence of necrosis in the primary tumor demonstrated a lower 5‐year disease‐specific survival compared with patients without necrosis in the primary tumor (36% vs. 75%; P < 0.0001). Multivariate analysis demonstrated that T classification (P < 0.0001), distant metastases (P < 0.0001), and ECOG PS (P < 0.0001) were independent predictors of DSS, whereas the presence of necrosis was not (P = 0.1100). Substratification into localized and metastatic disease demonstrated that the presence of necrosis was an independent predictor of survival in patients with localized (P = 0.025), but not metastatic (P = 0.44), disease. The extent of necrosis was not an independent predictor of survival (P > 0.05). Patients with the presence of necrosis in the primary tumor had a lower 5‐year disease recurrence‐free rate compared with patients without the presence of necrosis (62% vs. 92%, P < 0.0001). CONCLUSIONS: The presence of necrosis in the primary tumor was associated with adverse prognostic factors such as high T classification, presence of lymph node disease and metastases, high grade, large tumor size, and poor ECOG PS. The extent of necrosis was found to be associated with the presence of lymph node disease and metastases and correlated with higher T classification, higher grade, greater tumor size, poorer ECOG PS, and higher UISS category. The presence of this histologic variant was an independent predictor of poor survival in patients with localized, but not metastatic, disease. In addition, Ki‐67 expression served as a valuable surrogate marker for the presence of histologic tumor necrosis. Cancer 2005. © 2005 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.21127

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 173

Metadata

Authors
Lam, J. S., Shvarts, O., Said, J. W., Pantuck, A. J., Seligson, D. B., Aldridge, M. E., Bui, M. H. T., Liu, X., Horvath, S., Figlin, R. A., & Belldegrun, A. S.
Venue
Cancer
Publisher
Wiley
Published
2005-06-02
Volume
103
Issue
12
Pages
2517-2525
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1973148708
Cited by
173
References
2
FWCI
9.87
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. https://app.cochat.ai/papers/10.1002/cncr.21127
The paper
Lam, J. S., Shvarts, O., Said, J. W., Pantuck, A. J., Seligson, D. B., Aldridge, M. E., Bui, M. H. T., Liu, X., Horvath, S., Figlin, R. A., & Belldegrun, A. S. (2005). Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer. https://doi.org/10.1002/cncr.21127

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.